Sierra Oncology has received the US Food and Drug Administration’s (FDA) fast track designation for its investigational drug momelotinib. Indicated...
Read More...
The post FDA grants fast-track designation to bone marrow cancer drug appeared first on Pharmaceutical Technology.
Original Article: FDA grants fast-track designation to bone marrow cancer drug